Katherine Adkins - Nov 1, 2021 Form 4 Insider Report for Affirm Holdings, Inc. (AFRM)

Signature
/s/ David Ritenour, Attorney-in-Fact
Stock symbol
AFRM
Transactions as of
Nov 1, 2021
Transactions value $
-$1,752,546
Form type
4
Date filed
11/3/2021, 06:11 PM
Previous filing
Oct 5, 2021
Next filing
Nov 5, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AFRM Class A Common Stock Options Exercise $104K +1.66K +17.92% $62.52 10.9K Nov 1, 2021 Direct
transaction AFRM Class A Common Stock Options Exercise $0 +2.33K +21.28% $0.00 13.2K Nov 1, 2021 Direct
transaction AFRM Class A Common Stock Options Exercise $0 +165 +1.25% $0.00 13.4K Nov 1, 2021 Direct
transaction AFRM Class A Common Stock Tax liability -$172K -1.13K -8.41% $152.66* 12.3K Nov 1, 2021 Direct F1
transaction AFRM Class A Common Stock Sale -$182K -1.2K -9.77% $151.64* 11.1K Nov 1, 2021 Direct F2, F3
transaction AFRM Class A Common Stock Sale -$492K -3.23K -29.13% $152.41* 7.86K Nov 1, 2021 Direct F2, F4
transaction AFRM Class A Common Stock Sale -$138K -901 -11.47% $153.62* 6.96K Nov 1, 2021 Direct F2, F5
transaction AFRM Class A Common Stock Sale -$572K -3.7K -53.19% $154.63* 3.26K Nov 1, 2021 Direct F2, F6
transaction AFRM Class A Common Stock Sale -$77.6K -500 -15.36% $155.15* 2.76K Nov 1, 2021 Direct F2, F7
transaction AFRM Class A Common Stock Sale -$78.3K -500 -18.14% $156.65* 2.26K Nov 1, 2021 Direct F2, F8
transaction AFRM Class A Common Stock Sale -$94.7K -594 -26.33% $159.48* 1.66K Nov 1, 2021 Direct F2, F9
transaction AFRM Class A Common Stock Sale -$48.9K -300 -18.05% $162.93* 1.36K Nov 1, 2021 Direct F2, F10

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AFRM Stock Option (Right to Buy) Options Exercise $0 -1.66K -6.25% $0.00 24.9K Nov 1, 2021 Class A Common Stock 1.66K $62.52 Direct F11
transaction AFRM Restricted Stock Units Options Exercise $0 -2.33K -10% $0.00 20.9K Nov 1, 2021 Class A Common Stock 2.33K Direct F12, F13
transaction AFRM Restricted Stock Units Options Exercise $0 -165 -2.27% $0.00 7.12K Nov 1, 2021 Class A Common Stock 165 Direct F12, F14
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the number of shares of the Issuer's Common Stock withheld to satisfy the Reporting Person's tax obligation in connection with the settlement of shares of Common Stock underlying the Reporting Person's restricted stock units that vested on November 1, 2021.
F2 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2021.
F3 Represents the weighted average sale price of the shares sold from $151.03 to $151.98 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F4 Represents the weighted average sale price of the shares sold from $152.06 to $152.95 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F5 Represents the weighted average sale price of the shares sold from $153.10 to $153.99 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F6 Represents the weighted average sale price of the shares sold from $154.13 to $155.11 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F7 Represents the weighted average sale price of the shares sold from $155.13 to $155.17 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F8 Represents the weighted average sale price of the shares sold from $156.15 to $157.09 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F9 Represents the weighted average sale price of the shares sold from $158.99 to $159.93 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F10 Represents the weighted average sale price of the shares sold from $162.91 to $162.96 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F11 The stock option vests in 48 equal monthly installments after June 1, 2021, subject to the Reporting Person's continuous service with the Issuer as of each vesting date.
F12 Each Restricted Stock Unit (RSU) represents a contingent right to receive one share of the Issuer's Class A Common Stock.
F13 The RSUs vest in 24 equal monthly installments after August 1, 2022, subject to the Reporting Person's continuous service with the Issuer as of each vesting date.
F14 The RSUs vest in 48 equal monthly installments after June 1, 2021, subject to the Reporting Person's continuous service with the Issuer as of each vesting date. This grant has no expiration date.